FDA Inspection
Neway Medical, P.C.Neway Medical, P.C. – FDA Inspection, Mar 27, 2019
Record Details
This FDA Inspection record concerns Neway Medical, P.C., with an inspection on March 27, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · df966ba0-c1fc-41ea-867d-e6a9826d05fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084132
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Procedures for all other requirements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Neway Medical, P.C.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2024 | VAI | New York District Office | Human Cellular, Tissue, and Gene Therapies |
| November 8, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 22, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 30, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Neway Medical, P.C.
- FDA Inspection 1257382 - 2024-12-20
- FDA Inspection 1187485 - 2022-11-08
- FDA Inspection 996500 - 2016-12-21
- FDA Inspection 942650 - 2015-09-22
- FDA Inspection 841013 - 2013-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.